Reported Earnings • May 23
Full year 2026 earnings released: EPS: ₹0.28 (vs ₹11.39 in FY 2025) Full year 2026 results: EPS: ₹0.28 (down from ₹11.39 in FY 2025). Revenue: ₹3.67b (down 27% from FY 2025). Net income: ₹14.3m (down 97% from FY 2025). Profit margin: 0.4% (down from 11% in FY 2025). The decrease in margin was driven by lower revenue. お知らせ • May 18
Gem Aromatics Limited to Report Q4, 2026 Results on May 21, 2026 Gem Aromatics Limited announced that they will report Q4, 2026 results on May 21, 2026 Valuation Update With 7 Day Price Move • Mar 27
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₹145, the stock trades at a trailing P/E ratio of 27.1x. Average trailing P/E is 20x in the Chemicals industry in India. New Risk • Mar 13
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₹9.24b (US$99.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Profit margins are more than 30% lower than last year (6.1% net profit margin). Market cap is less than US$100m (₹9.24b market cap, or US$99.9m). New Risk • Feb 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Profit margins are more than 30% lower than last year (6.1% net profit margin). Valuation Update With 7 Day Price Move • Feb 03
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to ₹193, the stock trades at a trailing P/E ratio of 36x. Average trailing P/E is 22x in the Chemicals industry in India. Reported Earnings • Jan 28
Third quarter 2026 earnings released: ₹1.04 loss per share (vs ₹3.74 profit in 3Q 2025) Third quarter 2026 results: ₹1.04 loss per share (down from ₹3.74 profit in 3Q 2025). Revenue: ₹772.5m (down 48% from 3Q 2025). Net loss: ₹49.9m (down 129% from profit in 3Q 2025). New Risk • Jan 28
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.1% Last year net profit margin: 11% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (6.1% net profit margin). Market cap is less than US$100m (₹7.92b market cap, or US$86.4m). お知らせ • Jan 21
Gem Aromatics Limited to Report Q3, 2026 Results on Jan 27, 2026 Gem Aromatics Limited announced that they will report Q3, 2026 results on Jan 27, 2026 Valuation Update With 7 Day Price Move • Dec 05
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₹144, the stock trades at a trailing P/E ratio of 18.6x. Average trailing P/E is 24x in the Chemicals industry in India. New Risk • Nov 24
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₹8.84b (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (40% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Market cap is less than US$100m (₹8.84b market cap, or US$99.2m). Reported Earnings • Nov 15
Second quarter 2026 earnings released: ₹0.04 loss per share (vs ₹3.74 profit in 2Q 2025) Second quarter 2026 results: ₹0.04 loss per share (down from ₹3.74 profit in 2Q 2025). Revenue: ₹905.1m (down 40% from 2Q 2025). Net loss: ₹25.8m (down 115% from profit in 2Q 2025). お知らせ • Oct 16
Gem Aromatics Limited to Report Q2, 2026 Results on Nov 13, 2025 Gem Aromatics Limited announced that they will report Q2, 2026 results on Nov 13, 2025 Reported Earnings • Sep 13
First quarter 2026 earnings released First quarter 2026 results: EPS: ₹1.70. Net income: ₹79.8m (up ₹79.8m from 1Q 2025). お知らせ • Sep 09
Gem Aromatics Limited to Report Q1, 2026 Results on Sep 12, 2025 Gem Aromatics Limited announced that they will report Q1, 2026 results on Sep 12, 2025 Board Change • Aug 28
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Director Shubhangi Umbarkar was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.